Literature DB >> 11819725

Inhibitory effect and mechanism of acarbose combined with gymnemic acid on maltose absorption in rat intestine.

H Luo1, L F Wang, T Imoto, Y Hiji.   

Abstract

AIM: To compare the combinative and individual effect of acarbose and gymnemic acid (GA) on maltose absorption and hydrolysis in small intestine to determine whether nutrient control in diabetic care can be improved by combination of them.
METHODS: The absorption and hydrolysis of maltose were studied by cyclic perfusion of intestinal loops in situ and motility of the intestine was recorded with the intestinal ring in vitro using Wistar rats.
RESULTS: The total inhibitory rate of maltose absorption was improved by the combination of GA (0.1g/L-1.0 g/L) and acarbose (0.1 mmol/L-2.0 mmol/L) throughout their effective duration (P <0.05, U test of Mann-Whitney), although the improvement only could be seen at a low dosage during the first hour. With the combination, inhibitory duration of acarbose on maltose absorption was prolonged to 3h and the inhibitory effect onset of GA was fastened to 15 min. GA suppressed the intestinal mobility with a good correlation (r = 0.98) to the inhibitory effect of GA on maltose absorption and the inhibitory effect of 2 mmol/L (high dose) acarbose on maltose hydrolysis was dual modulated by 1g/L GA in vivo indicating that the combined effects involved the functional alteration of intestinal barriers.
CONCLUSION: There are augmented effects of acarbose and GA,which involve pre-cellular and paracellular barriers. Diabetic care can be improved by employing the combination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819725      PMCID: PMC4688708          DOI: 10.3748/wjg.v7.i1.9

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

1.  [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].

Authors:  C Jünger; W Rathmann; G Giani
Journal:  Dtsch Med Wochenschr       Date:  2000-02-04       Impact factor: 0.628

2.  Acarbose-induced acute severe hepatotoxicity.

Authors:  M Carrascosa; F Pascual; S Aresti
Journal:  Lancet       Date:  1997-03-08       Impact factor: 79.321

Review 3.  Adaptation of intestinal nutrient transport in health and disease. Part II.

Authors:  A B Thomson; G Wild
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

4.  Inhibition of ATPases by gymnemic acid.

Authors:  R B Koch; D Desaiah; L K Cutkomp
Journal:  Chem Biol Interact       Date:  1973-08       Impact factor: 5.192

Review 5.  Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.

Authors:  P E Jennings
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

6.  Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus.

Authors:  E R Shanmugasundaram; G Rajeswari; K Baskaran; B R Rajesh Kumar; K Radha Shanmugasundaram; B Kizar Ahmath
Journal:  J Ethnopharmacol       Date:  1990-10       Impact factor: 4.360

7.  Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance.

Authors:  H Kentrup; H Bongers; M Spengler; G Kusenbach; H Skopnik
Journal:  Eur J Pediatr       Date:  1999-06       Impact factor: 3.183

Review 8.  Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  S P Clissold; C Edwards
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 9.  Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus.

Authors:  J A Balfour; D McTavish
Journal:  Drugs       Date:  1993-12       Impact factor: 9.546

10.  Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.

Authors:  T Hayakawa; T Kondo; N Okumura; K Nagai; T Shibata; M Kitagawa
Journal:  Am J Gastroenterol       Date:  1989-05       Impact factor: 10.864

View more
  8 in total

1.  Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli.

Authors:  Ying Huang; Shu-Ren Wang; Cheng Yi; Ming-Ying Ying; Ying Lin; Mao-Hui Zhi
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats.

Authors:  X Q Sun; X B Fu; R Zhang; Y Lu; Q Deng; X G Jiang; Z Y Sheng
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Inhibitory effect of voglibose and gymnemic acid on maltose absorption in vivo.

Authors:  H Luo; T Imoto; Y Hiji
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  Gymnemic acid interacts with mammalian glycerol-3-phosphate dehydrogenase.

Authors:  Sumio Ishijima; Tomoyuki Takashima; Tomo Ikemura; Yusuke Izutani
Journal:  Mol Cell Biochem       Date:  2007-12-14       Impact factor: 3.396

5.  Decreased bodyweight without rebound and regulated lipoprotein metabolism by gymnemate in genetic multifactor syndrome animal.

Authors:  Hong Luo; Akiko Kashiwagi; Toshiyuki Shibahara; Kazuo Yamada
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

6.  Hypoglycemic Effects of Three Medicinal Plants in Experimental Diabetes: Inhibition of Rat Intestinal α-glucosidase and Enhanced Pancreatic Insulin and Cardiac Glut-4 mRNAs Expression.

Authors:  Leila Moradabadi; Shideh Montasser Kouhsari; Mohammad Fehresti Sani
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

7.  Antidiabetic properties and mechanism of action of Gynura procumbens water extract in streptozotocin-induced diabetic rats.

Authors:  Zurina Hassan; Mun Fei Yam; Mariam Ahmad; Ahmad Pauzi M Yusof
Journal:  Molecules       Date:  2010-12-08       Impact factor: 4.411

Review 8.  Traditional Indian medicines used for the management of diabetes mellitus.

Authors:  Syed Ibrahim Rizvi; Neetu Mishra
Journal:  J Diabetes Res       Date:  2013-06-05       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.